Radiological and Clinical Value of 7T MRI for Evaluating 3T-Visible Lesions in Pharmacoresistant Focal Epilepsies

Objective: The recent FDA approval of the first 7T MRI scanner for clinical diagnostic use in October 2017 will likely increase the utilization of 7T for epilepsy presurgical evaluation. This study aims at accessing the radiological and clinical value of 7T in patients with pharmacoresistant focal e...

Full description

Bibliographic Details
Main Authors: Z. Irene Wang, Se-Hong Oh, Mark Lowe, Mykol Larvie, Paul Ruggieri, Virginia Hill, Volodymyr Statsevych, Doksu Moon, Jonathan Lee, Todd Emch, James Bena, Ingmar Blümcke, William Bingaman, Jorge A. Gonzalez-Martinez, Imad Najm, Stephen E. Jones
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Neurology
Subjects:
MRI
7T
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.591586/full